Lincoln Pharma Q4 FY26 Net Profit ₹11.63 Cr, Recommends 18% Dividend

Lincoln Pharmaceuticals Limited announced its audited financial results for the quarter and year ended March 31, 2026. For Q4 FY26, the company reported a standalone net profit of ₹11.63 crore on revenue from operations of ₹187.28 crore. For the full fiscal year FY26, standalone net profit stood at ₹87.89 crore, with revenue from operations reaching ₹671.03 crore. The Board of Directors also recommended a dividend of 18% (₹1.80 per share) for the year ended March 31, 2026, subject to approval at the upcoming Annual General Meeting.